Navigation auf uzh.ch
Navigation auf uzh.ch
1. Sparano C, Solis-Sayago D, Vijaykumar A, Rickenbach C, Vermeer M, Ingelfinger F, Fonseca A, Mussak C, Mayoux M, Friedrich C, Nombela-Arrieta C, Gasteiger G, Becher B, Tugues S (2022). Embryonic and neonatal waves generate distinct populations of hepatic ILC1s. Science Immunology, July 2.
2. Ducimetiere L*, Lucchiari G*, Litscher G, Nater M, Heeb L, Núñez NG, Wyss L, Burri D, Vermeer M, Gschwendt G, Moor AE, Becher B, van den Broek M#, Tugues S# (2021). Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc Natl Acad Sci USA, July 6.
3. Ducimetiere L, Vermeer M, Tugues S (2019). The Interplay between innate lymphoid cells and the tumor microenvironment. Frontiers in Immunology, Dec 13.
4. Tugues S*#, Amorim A*, Spath S*, Martin-Blondel G, Schreiner B, De Feo D, Lutz M, Guscetti F, Apostolova P, Haftmann C, Hasselblatt P, Nunez N, Hottiger MO, van den Broek M, Manz MG, Zeiser R, Becher B (2018). GM-CSF-licensed myeloid cells mediate graft-vs-host disease uncoupling immunopathology from graft-vs-leukemia. Science Translational Medicine, Nov; 10:1-12.
5. Tugues S*, Ducimetiere L, Friebel E, Becher B. (2019). Innate lymphoid cells as regulators of the tumor microenvironment. Seminars in Immunology, March 11.
6. Ohs I, Ducimetiere L, Marinho J, Kulig P, Becher B#, Tugues S# (2017). Restoration of natural killer cell anti-metastatic activity by IL-12 and checkpoint blockade. Cancer Research, Dec; 77: 7059-7071.
7. Ohs I, van den Broek M, Nussbaum K, Münz C, Arnold SJ, Quezada SA, Tugues S*, Becher B* (2016). Interleukin-12 bypasses common gamma-chain signaling in emergency natural killer cell lymphopoiesis. Nature Communications, Dec; 7:13708.
Link to all publications
